Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Zalicus, Inc.
Pharmaceutical Preparations MA, United States
Nasdaq: ZLCS
Company Description
Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The company has a portfolio of clinical-stage product candidates targeting pain and immuno-inflammatory diseases. It has two subsidiaries: Zalicus Pharmaceuticals Ltd. and Zalicus Securities Corp. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
Similar to: AstraZeneca Plc, Trius Therapeutics, Inc., ViroPharma, Inc.
Featured Company
Nature Group Plc
St. Helier, JE, GB
NATURE GROUP is the market leader in handling Marpol and offshore waste, with more than 25 years’ collection and treatment experience.… Learn more →
Social Monitor
You may also be interested in:
ViroPharma, Inc.
Exton, PA, US
ViroPharma is rare among biotechnology companies. We are in the enviable position of having a strong and growing balance sheet; a… Learn more →
Trius Therapeutics, Inc.
San Diego, CA, US
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →